Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative ...

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

This new study featured the results from the STEP 9 phase 3 clinical trial conducted by healthcare company Novo Nordisk aimed ...

Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Real progress in health inequities requires meeting communities where they are and addressing the root causes of medical ...

Healthcare leaders should not think about technology first and the allure of AI, says Sutter Health’s Kiran Mysore.

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all types of MS.

The incidence of breast cancer has increased from 900 000 to 2.3 million new annual cases over the last 25 years. The 5-year ...

In Louisiana and across the country, pancreatic cancer continues to be one of the most aggressive and deadly forms of the ...